Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Drug Resistance

  Free Subscription


Articles published in Emerg Infect Dis

Retrieve available abstracts of 74 articles:
HTML format



Single Articles


    November 2025
  1. SEUNG KJ, Asfaw M, Kunda M, Maama-Maime LB, et al
    Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho.
    Emerg Infect Dis. 2025;31:2185-2187.
    PubMed     Abstract available


  2. BEALL B, Lin W, Li Z, Tran T, et al
    Two Independent Acquisitions of Multidrug Resistance Gene lsaC in Streptococcus pneumoniae Serotype 20 Multilocus Sequence Type 1257.
    Emerg Infect Dis. 2025;31:2098-2108.
    PubMed     Abstract available


    October 2025
  3. MIZUSHIMA H, Komori M, Yoshida CA, Miyairi I, et al
    Neonatal Gonococcal Conjunctivitis Caused by Fluoroquinolone-Resistant Neisseria gonorrhoeae.
    Emerg Infect Dis. 2025;31:2043-2045.
    PubMed     Abstract available


  4. CARTEE JC, Cherdtrakulkiat T, Joseph SJ, Kittiyaowamarn R, et al
    Antimicrobial-Resistant Clonal Complex 11 Neisseria meningitidis-Associated Urethritis Cluster, Thailand.
    Emerg Infect Dis. 2025;31:1992-1997.
    PubMed     Abstract available


  5. PERRY J, Rakler T, Arnold K, Wiseman A, et al
    Multidrug-Resistant pESI-Harboring Salmonella enterica Serovar Muenchen Sequence Type 82 in Poultry and Humans, Israel, 2020-2023.
    Emerg Infect Dis. 2025;31:1969-1979.
    PubMed     Abstract available


  6. RABAULT C, Shuping L, Mpembe R, Quan V, et al
    Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012-2017.
    Emerg Infect Dis. 2025;31:1901-1911.
    PubMed     Abstract available


    September 2025
  7. DO PRADO CM, Spruijtenburg B, Razzolini E, Chiyo L, et al
    Sporothrix brasiliensis Treatment Failure without Initial Elevated Itraconazole MICs in Felids at Border of Brazil.
    Emerg Infect Dis. 2025;31:1783-1792.
    PubMed     Abstract available


    August 2025
  8. LAN S, Liu S, Cui W, Li Z, et al
    Emergence of Novel Fluoroquinolone Resistance Mutations in Mycoplasma bovis, China, 2008-2023.
    Emerg Infect Dis. 2025;31:1676-1679.
    PubMed     Abstract available


    July 2025
  9. HOODA Y, Tanmoy AM, Nath SD, Jui AB, et al
    Outbreak of Ceftriaxone-Resistant Salmonella enterica Serovar Typhi, Bangladesh, 2024.
    Emerg Infect Dis. 2025;31:1460-1465.
    PubMed     Abstract available


  10. LEFEBVRE B, Martin I, Thorington R, Gitelman J, et al
    Extensively Drug-Resistant Neisseria gonorrhoeae Strain, Canada.
    Emerg Infect Dis. 2025;31:1446-1449.
    PubMed     Abstract available


  11. CHARLES H, Greig DR, Swift C, Olonade I, et al
    Epidemiologic and Genomic Investigation of Sexually Transmitted Shigella sonnei, England.
    Emerg Infect Dis. 2025;31:1394-1405.
    PubMed     Abstract available


  12. DELMA FZ, Spruijtenburg B, Meis JF, de Jong AW, et al
    Emergence of Flucytosine-Resistant Candida tropicalis Clade, the Netherlands.
    Emerg Infect Dis. 2025;31:1354-1364.
    PubMed     Abstract available


    June 2025
  13. DU T, Silva A, Choi KB, Lybeck C, et al
    Characterization of Adult and Pediatric Healthcare-Associated and Community-Associated Clostridioides difficile Infections, Canada, 2015-2022.
    Emerg Infect Dis. 2025;31:1109-1120.
    PubMed     Abstract available


    May 2025
  14. DE ALMEIDA JN JR, Dos Santos AR, Trindade MRS, Gold JAW, et al
    Trichophyton indotineae Infection, Sao Paulo, Brazil, 2024.
    Emerg Infect Dis. 2025;31:1049-1051.
    PubMed     Abstract available


  15. LI L, Wang X, Xiao Y, Fan B, et al
    Rapid Transmission and Divergence of Vancomycin-Resistant Enterococcus faecium Sequence Type 80, China.
    Emerg Infect Dis. 2025;31:1000-1005.
    PubMed     Abstract available


  16. ABOU-CHAKRA N, Astvad KMT, Martinussen J, Munksgaard ASE, et al
    Exponential Clonal Expansion of 5-Fluorocytosine-Resistant Candida tropicalis and New Insights into Underlying Molecular Mechanisms.
    Emerg Infect Dis. 2025;31:977-985.
    PubMed     Abstract available


  17. TAKASHITA E, Morita H, Nagata S, Fujisaki S, et al
    Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024.
    Emerg Infect Dis. 2025;31:1019-1023.
    PubMed     Abstract available


  18. LLOYD T, Khan SM, Heaton D, Shemsu M, et al
    Genomic Modeling of an Outbreak of Multidrug-Resistant Shigella sonnei, California, USA, 2023-2024.
    Emerg Infect Dis. 2025;31:98-102.
    PubMed     Abstract available


  19. MIERNYK KM, Chochua S, Metcalf B, Reasonover A, et al
    Successful Transition to Whole-Genome Sequencing and Bioinformatics to Identify Invasive Streptococcus spp. Drug Resistance, Alaska, USA.
    Emerg Infect Dis. 2025;31:103-108.
    PubMed     Abstract available


  20. TORRES LM, Johnson J, Valentine A, Brezak A, et al
    Integrating Genomic Data into Public Health Surveillance for Multidrug-Resistant Organisms, Washington, USA.
    Emerg Infect Dis. 2025;31:25-34.
    PubMed     Abstract available


    April 2025
  21. SAVIN C, Oropeza G, Barboza Fallas LA, Rivas-Solano O, et al
    Genomic Characterization of Yersinia enterocolitica Isolates, Costa Rica.
    Emerg Infect Dis. 2025;31:848-860.
    PubMed     Abstract available


  22. PEREYRE S, Laurier-Nadalie C, Balcon C, Henin N, et al
    Spread of Dual-Resistant Mycoplasma genitalium Clone among Men, France, 2021-2022.
    Emerg Infect Dis. 2025;31:854-858.
    PubMed     Abstract available


  23. PASCUA PNQ, Chesnokov A, Nguyen HT, Di H, et al
    Antiviral Susceptibility of Influenza A(H5N1) Clade 2.3.2.1c and 2.3.4.4b Viruses from Humans, 2023-2024.
    Emerg Infect Dis. 2025;31:751-760.
    PubMed     Abstract available


    March 2025
  24. JIANG J, Long T, Porter AR, Lovey A, et al
    Carbapenem-Resistant, Virulence Plasmid-Harboring Klebsiella pneumoniae, United States.
    Emerg Infect Dis. 2025;31.
    PubMed     Abstract available


  25. PAUL R, Lorenzo F, Lopez B, Alegre MG, et al
    Outbreak Caused by Multidrug-Resistant Mycobacterium Tuberculosis with Unusual Combination of Resistance Mutations, Northern Argentina, 2006-2022.
    Emerg Infect Dis. 2025;31:601-606.
    PubMed     Abstract available


  26. GERUSSI V, Petersen T, Bonnet I, Aubry A, et al
    Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment.
    Emerg Infect Dis. 2025;31:633-636.
    PubMed     Abstract available


  27. FRANCISCO NM, Gaviraghi A, Alladio F, Huits R, et al
    Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola.
    Emerg Infect Dis. 2025;31:627-629.
    PubMed     Abstract available


  28. KONSTANTYNOVSKA O, Synenko T, Honcharenko A, Volobuieva O, et al
    Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023.
    Emerg Infect Dis. 2025;31:615-617.
    PubMed     Abstract available


  29. SHAO Y, Chen M, Cai J, Doi Y, et al
    Cefotaxime-Resistant Neisseria meningitidis Sequence Type 4821 Causing Fulminant Meningitis.
    Emerg Infect Dis. 2025;31:591-595.
    PubMed     Abstract available


  30. LEBER AL, Embry T, Everhart K, Taveras J, et al
    Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.
    Emerg Infect Dis. 2025;31:555-558.
    PubMed     Abstract available


  31. ZIMENKOV D, Ushtanit A, Gordeeva E, Guselnikova E, et al
    High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia.
    Emerg Infect Dis. 2025;31:525-536.
    PubMed     Abstract available


  32. DU PLESSIS M, Mikhari R, de Gouveia L, Duma N, et al
    Corynebacterium diphtheriae Infections, South Africa, 2015-2023.
    Emerg Infect Dis. 2025;31:417-426.
    PubMed     Abstract available


    January 2025
  33. ABDOLRASOULI A, Barton RC, Borman AM
    Spread of Antifungal-Resistant Trichophyton indotineae, United Kingdom, 2017-2024.
    Emerg Infect Dis. 2025;31:192-194.
    PubMed     Abstract available


  34. MACFARQUHAR JK, Bajpai A, Fisher T, Barr C, et al
    Identification and Characterization of Vancomycin-Resistant Staphylococcus aureus CC45/USA600, North Carolina, USA, 2021.
    Emerg Infect Dis. 2025;31:194-196.
    PubMed     Abstract available


  35. BRODIKOVA K, Destanque T, Haenni M, Karpiskova R, et al
    Clonal Complex 398 Methicillin-Resistant Staphylococcus aureus Producing Panton-Valentine Leukocidin, Czech Republic, 2023.
    Emerg Infect Dis. 2025;31:174-177.
    PubMed     Abstract available


  36. POLANI R, De Francesco A, Tomolillo D, Artuso I, et al
    Cefiderocol Resistance Conferred by Plasmid-Located Ferric Citrate Transport System in KPC-Producing Klebsiella pneumoniae.
    Emerg Infect Dis. 2025;31:123-124.
    PubMed     Abstract available


  37. STROBEL AG, Sahukhan A, Ratu A, Kailawadoko J, et al
    Meningococcal C Disease Outbreak Caused by Multidrug-Resistant Neisseria meningitidis, Fiji.
    Emerg Infect Dis. 2025;31:32-40.
    PubMed     Abstract available


    December 2024
  38. PRICE ER, McDermott D, Sherman A, Kelley L, et al
    Canine Multidrug-Resistant Pseudomonas aeruginosa Cases Linked to Human Artificial Tears-Related Outbreak.
    Emerg Infect Dis. 2024;30:2689-2691.
    PubMed     Abstract available


  39. JIRAWATTANADON P, Bunyaratavej S, Leeyaphan C, Chongtrakool P, et al
    Clinical Manifestations, Antifungal Drug Susceptibility, and Treatment Outcomes for Emerging Zoonotic Cutaneous Sporotrichosis, Thailand.
    Emerg Infect Dis. 2024;30:2583-2592.
    PubMed     Abstract available


    November 2024
  40. TSENG KY, Chen YZ, Zhou ZL, Tsai JN, et al
    Detection in Orchards of Predominant Azole-Resistant Candida tropicalis Genotype Causing Human Candidemia, Taiwan.
    Emerg Infect Dis. 2024;30:2323-2332.
    PubMed     Abstract available


  41. GHOSH M, Iarikov D, Qi XK, Rubin D, et al
    Flexible Development Programs for Antibacterial Drugs to Address Unmet Medical Needs.
    Emerg Infect Dis. 2024;30:2227-2230.
    PubMed     Abstract available


  42. GAO R, Pascua PNQ, Chesnokov A, Nguyen HT, et al
    Antiviral Susceptibility of Swine-Origin Influenza A Viruses Isolated from Humans, United States.
    Emerg Infect Dis. 2024;30:2303-2312.
    PubMed     Abstract available


    October 2024
  43. FRENCH NP, Thomas KM, Amani NB, Benschop J, et al
    Population Structure and Antimicrobial Resistance in Campylobacter jejuni and C. coli Isolated from Humans with Diarrhea and from Poultry, East Africa.
    Emerg Infect Dis. 2024;30:2079-2089.
    PubMed     Abstract available


  44. ODUNDO EA, Kipkirui EC, Koech MC, Kirui MC, et al
    Azithromycin Resistance Patterns in Escherichia coli and Shigella before and after COVID-19, Kenya.
    Emerg Infect Dis. 2024;30:86-93.
    PubMed     Abstract available


  45. LE VAN A, Rahman N, Sandy R, Dozier N, et al
    Common Patterns and Unique Threats in Antimicrobial Resistance as Demonstrated by Global Gonococcal Surveillance.
    Emerg Infect Dis. 2024;30:62-70.
    PubMed     Abstract available


  46. ANDERSON C, Lebreton F, Mills E, Jones B, et al
    Molecular Surveillance of Multidrug-Resistant Bacteria among Refugees from Afghanistan in 2 US Military Hospitals during Operation Allies Refuge, 2021.
    Emerg Infect Dis. 2024;30:47-52.
    PubMed     Abstract available


  47. BYARUGABA DK, Osman TS, Sayyouh OM, Wokorach G, et al
    Genomic Epidemiology of Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae in Kenya, Uganda, and Jordan.
    Emerg Infect Dis. 2024;30:33-40.
    PubMed     Abstract available


    September 2024
  48. GOLD JAW, Benedict K, Lockhart SR, Lutfy C, et al
    Recognition of Antifungal-Resistant Dermatophytosis by Infectious Diseases Specialists, United States.
    Emerg Infect Dis. 2024;30:1978-1980.
    PubMed     Abstract available


  49. CAMELENA F, Merimeche M, Brousseau J, Mainardis M, et al
    Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023.
    Emerg Infect Dis. 2024;30:1903-1906.
    PubMed     Abstract available


    August 2024
  50. WU TH, Fang YP, Liu FC, Pan HH, et al
    Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017-2023.
    Emerg Infect Dis. 2024;30:1692-1696.
    PubMed     Abstract available


  51. XIU L, Zhang L, Peng J
    Surge in Ceftriaxone-Resistant Neisseria gonorrhoeae FC428-Like Strains, Asia-Pacific Region, 2015-2022.
    Emerg Infect Dis. 2024;30:1683-1686.
    PubMed     Abstract available


  52. BAUM M, Anuka E, Davidovich-Cohen M, Rokney A, et al
    ST913-IVa-t991 Methicillin-Resistant Staphylococcus aureus among Pediatric Patients, Israel.
    Emerg Infect Dis. 2024;30:1714-1718.
    PubMed     Abstract available


  53. MCQUAID CF, Ryckman TS, Menzies NA, White RG, et al
    Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance.
    Emerg Infect Dis. 2024;30:1571-1579.
    PubMed     Abstract available


  54. ARENDRUP MC, Hare RK, Jorgensen KM, Bollmann UE, et al
    Environmental Hot Spots and Resistance-Associated Application Practices for Azole-Resistant Aspergillus fumigatus, Denmark, 2020-2023.
    Emerg Infect Dis. 2024;30:1531-1541.
    PubMed     Abstract available


    July 2024
  55. OUK V, Say HL, Virak M, Deng S, et al
    World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023.
    Emerg Infect Dis. 2024;30:1493-1495.
    PubMed     Abstract available


  56. PATEL MC, Nguyen HT, Pascua PNQ, Gao R, et al
    Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023-February 2024.
    Emerg Infect Dis. 2024;30:1410-1415.
    PubMed     Abstract available


    June 2024
  57. YANG Y, Xu S, He H, Zhu X, et al
    Yersinia ruckeri Infection and Enteric Redmouth Disease among Endangered Chinese Sturgeons, China, 2022.
    Emerg Infect Dis. 2024;30:1125-1132.
    PubMed     Abstract available


  58. MANGALEA MR, Halpin AL, Haile M, Elkins CA, et al
    Decolonization and Pathogen Reduction Approaches to Prevent Antimicrobial Resistance and Healthcare-Associated Infections.
    Emerg Infect Dis. 2024;30:1069-1076.
    PubMed     Abstract available


  59. GROME HN, Grass JE, Duffy N, Bulens SN, et al
    Carbapenem-Resistant and Extended-Spectrum beta-Lactamase-Producing Enterobacterales in Children, United States, 2016-2020.
    Emerg Infect Dis. 2024;30:1104-1114.
    PubMed    


    May 2024
  60. DHABAAN G, Jamal H, Ouellette D, Alexander S, et al
    Detection of OXA-181 Carbapenemase in Shigella flexneri.
    Emerg Infect Dis. 2024;30:1048-1050.
    PubMed     Abstract available


  61. ABBARA S, Guillemot D, Smith DRM, El Oualydy S, et al
    Antimicrobial Resistance as Risk Factor for Recurrent Bacteremia after Staphylococcus aureus, Escherichia coli, or Klebsiella spp. Community-Onset Bacteremia.
    Emerg Infect Dis. 2024;30:974-983.
    PubMed     Abstract available


  62. NGUYEN DD, Ho NT, Dover LG, Vo AHM, et al
    Novel Variant and Known Mutation in 23S rRNA Gene of Mycoplasma pneumoniae, Northern Vietnam, 2023.
    Emerg Infect Dis. 2024;30:1034-1036.
    PubMed     Abstract available


    April 2024
  63. DOI A, Ota M, Saito M, Matsuyama S, et al
    Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  64. MATTOCK J, Chattaway MA, Hartman H, Dallman TJ, et al
    A One Health Perspective on Salmonella enterica Serovar Infantis, an Emerging Human Multidrug-Resistant Pathogen.
    Emerg Infect Dis. 2024;30:701-710.
    PubMed     Abstract available


  65. SPIVACK S, Gold JAW, Lockhart SR, Anand P, et al
    Potential Sexual Transmission of Antifungal-Resistant Trichophyton indotineae.
    Emerg Infect Dis. 2024;30:807-809.
    PubMed     Abstract available


    January 2024
  66. MULCHANDANI R, Zhao C, Tiseo K, Pires J, et al
    Predictive Mapping of Antimicrobial Resistance for Escherichia coli, Salmonella, and Campylobacter in Food-Producing Animals, Europe, 2000-2021.
    Emerg Infect Dis. 2024;30:96-104.
    PubMed     Abstract available


    November 2023
  67. MODONGO C, Barilar I, Wang Q, Molefi T, et al
    Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana.
    Emerg Infect Dis. 2023;29:2403-2406.
    PubMed     Abstract available


  68. JACQUELINE C, Carrascoso GR, Gutierrez-Fernandez J, Rangel TV, et al
    Genetic Characterization of Extensively Drug-Resistant Shigella sonnei Infections, Spain, 2021-2022.
    Emerg Infect Dis. 2023;29:2370-2373.
    PubMed     Abstract available


  69. CIAPPONI A, Bardach A, Sandoval MM, Palermo MC, et al
    Systematic Review and Meta-analysis of Deaths Attributable to Antimicrobial Resistance, Latin America.
    Emerg Infect Dis. 2023;29:2335-2344.
    PubMed     Abstract available


  70. NIZAMUDDIN S, Khan EA, Chattaway MA, Godbole G, et al
    Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022.
    Emerg Infect Dis. 2023;29:2395-2397.
    PubMed     Abstract available


  71. WU Y, Jiang T, He X, Shao J, et al
    Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant bla(OXA-232)-Carrying Klebsiella pneumoniae Sequence Type 15 Lineage.
    Emerg Infect Dis. 2023;29:2246-2256.
    PubMed     Abstract available


    October 2023
  72. HAMILTON KA, Njoroge SM, Momanyi K, Murungi MK, et al
    Antimicrobial Resistance in Slaughterhouses, Kenya.
    Emerg Infect Dis. 2023;29:2155-2158.
    PubMed     Abstract available


  73. LEE J, Sunny S, Nazarian E, Fornek M, et al
    Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016-2022.
    Emerg Infect Dis. 2023;29:1973-1978.
    PubMed     Abstract available


    January 2023
  74. FU P, Zhou J, Yang C, Nijiati Y, et al
    Molecular Evolution and Increasing Macrolide Resistance of Bordetella pertussis, Shanghai, China, 2016-2022.
    Emerg Infect Dis. 2023;30:29-38.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.